Quick Answer
Microbot Medical Inc. reported Operating Income of -$14.74 million for fiscal year 2025.
Microbot Medical Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$14.74M | -26.8% |
| 2024 | -$11.62M | -18.0% |
| 2023 | -$9.86M | +25.8% |
| 2022 | -$13.28M | -16.9% |
| 2021 | -$11.36M | -25.0% |
| 2020 | -$9.09M | -25.5% |
| 2019 | -$7.24M | +0.1% |
| 2018 | -$7.24M | -237.5% |
| 2017 | $5.27M | +154.7% |
| 2016 | -$9.63M | -1153.0% |
| 2015 | $915.0K | +103.0% |
| 2014 | -$30.91M | +0.0% |
| 2014 | -$30.91M | -10.0% |
| 2013 | -$28.09M | -28.2% |
| 2012 | -$21.91M | +22.0% |
| 2011 | -$28.08M | +4.4% |
| 2010 | -$29.36M | +0.1% |
| 2009 | -$29.38M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.86M | -17.0% | -3.7% |
| June 30, 2025 | -$3.72M | -48.3% | -23.2% |
| March 31, 2025 | -$3.02M | -26.7% | +8.5% |
| September 30, 2024 | -$3.30M | -29.7% | -31.4% |
| June 30, 2024 | -$2.51M | -8.0% | -5.3% |
| March 31, 2024 | -$2.38M | +18.3% | +6.3% |
| September 30, 2023 | -$2.54M | +26.8% | -9.5% |
| June 30, 2023 | -$2.32M | +34.8% | +20.4% |
- Microbot Medical Inc. showed a decrease of -26.8% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, Microbot Medical Inc.’s operating income has grown by 49.8% (from -$29.38 million to -$14.74 million).
- The most recent figure is from Microbot Medical Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: